{
    "medicine_id": "29ad121840396908923b979bf11fa696c3c636e9",
    "platform_id": "DB06215",
    "metadata": {
        "name": "Feraheme 510 mg 17mL Injection",
        "composition": "510 mg 17mL Ferumoxytol",
        "clinical_particulars": {
            "therapeutic_indications": "This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron or have experienced an unsatisfactory response to oral iron or who have chronic kidney disease CKD FDA label",
            "contraindications": {
                "disease": "Hypersensitivity The FDA has Feraheme ferumoxytol may cause serious hypersensitivity reactions including anaphylaxis and or anaphylactoid reactions Serious hypersensitivity reactions were reported in 0 2 3 1 726 of subjects administered Feraheme Some other reactions potentially associated with hypersensitivity e g pruritus rash urticaria or wheezing were reported in 3 7 63 1 726 of these subjects It is necessary to monitor patients for signs and symptoms of hypersensitivity for at least 30 minutes following Feraheme injection and limit administration of the drug only to when personnel and therapies are readily available for the treatment of hypersensitivity reactions FDA label Ferumoxytol was not tested for carcinogenic effects In general genotoxicity tests ferumoxytol showed no evidence of mutagenic activity in an in vitro Ames test or clastogenic activity in either an in vitro chromosomal aberration assay or an in vivo micronucleus assay No adverse effects on fertility were observed in animal studies Ferumoxytol had no effect on male or female fertility or general reproductive function in rats FDA label Hypotension Feraheme may cause significant hypotension In a clinical study with Feraheme in patients with IDA regardless of etiology moderate hypotension was reported in 0 2 of subjects receiving Feraheme administered as intravenous infusion for at least 15 minutes FDA label Iron overload Excessive therapy with parenteral iron may lead to excess storage of iron with a possibility of iatrogenic hemosiderosis Frequently monitor the hematologic response during parenteral iron therapy It is advised not to administer Feraheme to patients with iron overload FDA label A note on MRI studies Administration of Feraheme may transiently affect the diagnostic ability of MR imaging Anticipated MR imaging studies should be done before the administration of Feraheme Alteration of MRI imaging studies may persist for up to 12 weeks after the last Feraheme dose FDA label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The pharmacodynamic effect of ferumoxytol on hematologic indexes such as Hgb hemoglobin serum ferritin and TSAT transferrin saturation were studied and measured as primary and secondary endpoints in clinical efficacy studies L2187 Feraheme ferumoxytol reached the primary endpoint with statistical significance p 0 001 in all three trials versus oral iron L2187 Ferumoxytol has been examined as a contrast agent for magnetic resonance imaging MRI studies Because ferumoxytol is a very small superparamagnetic iron oxide USPIO with a polysaccharide coating it may be administered via the intravenous bolus route without mast cell degranulation which is an attributable property for magnetic resonance angiography and perfusion imaging Unlike gadolinium ferumoxytol crosses the blood brain barrier at a slow pace and is considered a blood pool agent Ferumoxytol stays in the intravascular space and offers a longer time period for data acquisition during an MRI study so that data can be repeatedly obtained over a period of several minutes to hours with only small losses of intravascular signal intensity and minimal soft tissue enhancement L2190 Iron containing proteins and enzymes are important in oxidation reduction reactions particularly those in the mitochondria Iron is a part of myoglobin and several heme enzymes including the cytochromes _catalase_ and _peroxidase_ Iron is an essential component of the m_etalloflavoprotein_ enzymes and the mitochondrial enzyme _alpha glycerophosphate oxidase_ In addition iron is a cofactor for enzymes such as _aconitase_ and _tryptophan pyrrolase_ Iron deficiency cause anemia and decreased oxygen delivery This also reduces the metabolism of muscle and decreases mitochondrial activity Iron deficiency may also cause defects in both learning or thermoregulation Therefore iron is important to several metabolic functions in addition to erythropoiesis L2190",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may increase the nephrotoxic activities of Ferumoxytol"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "The serum concentration of Deferiprone can be decreased when it is combined with Ferumoxytol"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Methyldopa resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Technetium Tc 99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "The serum concentration of Ferumoxytol can be decreased when it is combined with Triethylenetetramine"
                    },
                    {
                        "drugbank-id": "DB02369",
                        "description": "Ferumoxytol can cause a decrease in the absorption of 3 Aza 2 3 Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02423",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Thiopyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02552",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Geranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04160",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05143",
                        "description": "Ferumoxytol can cause a decrease in the absorption of OXI 4503 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09147",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Sodium phosphate monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11493",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13995",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14481",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14523",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Technetium Tc 99m oxidronate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The absorption of Ferumoxytol can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Ferumoxytol can cause a decrease in the absorption of Carbidopa resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}